Schedule 13G ownership disclosure

European Biotech Acquisition Corp.

Security class unavailable · CUSIP: G3167F110

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
21.9200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-22-002220
Form type
SC 13G
Filer
European Biotech Acquisition Corp.
CIK
CIK 1841258
Filed
Feb 08, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub